1 min read
1 min read

Webinar | An Overview of the Main Regulatory Issues Affecting the Pharmaceutical Industry

With the existence of a wide variety of regulatory approaches in the different knowledge areas, it becomes a priority to encourage regulatory harmonization. As the global market becomes more critical, pharmaceutical companies will require more significant cooperation among national regulators to get life saving products to market faster and minimize issues with regulatory compliance.

  • Are the current regulatory frameworks ready to support innovation?

  • Balancing opportunities and challenges

  • Novel regulatory pathways and approaches

  • Protecting trade secrets in the medical product approval process

  • Compounding: challenges for the (bio)pharmaceutical industry

  • What are the major impacts of new regulations on drug manufacturing?

  • How to handle changes and variations in a changing environment and a global market

SPEAKERS

  • Moderator: Sarah Hardison, Head of Regulatory, Clarivate Analytics

  • Aimad Torqui, Director of Global Regulatory Policy, MSD

  • Chris Rojewski, Associate Director, Regulatory Affairs Lead, Pfizer CentreOne

  • Gary Chambers, Global Head Life Sciences, SGS

  • Hanneke Later-Nijland, Partner, Axon Life Sciences Lawyers

  • Katherine Dutmer, General Counsel, Business Lawyer, Legal Project Manager, GC Legal Services

Watch the webinar here.